Skip to content

Columbia Ventures Corporation

Creating, Discovering and Enhancing Capital Values

Team
Philosophy
Portfolio
News
Contact

Saladax Biomedical gets CE mark for antipsychotic drug POC Test

Read now on 360dx.com • September 5, 2019

Like this:

Like Loading...

Author Columbia VenturesPosted on September 5, 2019September 6, 2019Categories BIOMEDICAL, Saladax Biomedical

Post navigation

Previous Previous post: Communications company moves to Isaacs

Next Next post: Saladax develops first-ever rapid test for an antipsychotic drug using a single drop of blood to aid psychiatrists in the treatment of schizophrenia

Recent News

2degrees and Lynk Global will bring satellite-to-phone coverage to New Zealand May 18, 2023
Four years after CES, Breadbot’s robotic breadmaker is dishing out loaves at grocery stores May 2, 2023
RealWear unveils next generation assisted reality headset for modern frontline professional with all April 18, 2023

Copyright © Columbia Ventures Corporation. All Rights Reserved.

News by Industry/Company

News by Industry/Company

Search Site

Search for:

Team
Philosophy
Portfolio
News
Contact

Columbia Ventures Corporation

Follow Following
- Columbia Ventures Corporation
- Already have a WordPress.com account? Log in now.

%d bloggers like this: